Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Genmab reported DKK1.96B in Current Liabilities for its fiscal quarter ending in March of 2023.

Current Liabilities Change
Agios Pharmaceuticals AGIO:US USD 45.11M 17.52M
Almirall SA ALM:SM EUR 274.61M 30.21M
Amarin AMRN:US USD 244.24M 15.24M
Amgen AMGN:US USD 14.22B 1.47B
Artemis Alpha ATS:LN GBP 7.42M 2.04M
AstraZeneca AZN:LN USD 24.86B 1.43B
Bayer BAYN:GR EUR 34.39B 693M
BioMarin Pharmaceutical BMRN:US USD 598.23M 9.35M
Bluebird Bio BLUE:US USD 115.93M 12.3M
Demant A/s WDH:DC DKK 11.57B 1.16B
Exelixis EXEL:US USD 327.6M 3.24M
Galapagos GLPG:NA EUR 522.9M 366K
Genmab GEN:DC DKK 1.96B 132M
GlaxoSmithKline GSK:LN GBP 20.7B 2.11B
GN Store Nord GN:DC DKK 9.02B 2.72B
Hikma Pharmaceutical HIK:LN USD 1.08B 67M
Immunogen IMGN:US USD 101.63M 20.23M
Insmed INSM:US USD 187.98M 2.26M
Lonza Group LONN:SW CHF 3.08B 454M
Merck MRK:GR EUR 9.56B 43M
Novartis NOVN:VX USD 30.55B 1.89B
Regeneron Pharmaceuticals REGN:US USD 3.1B 41.2M
Roche Holding ROG:VX CHF 27.24B 170M
Seattle Genetics SGEN:US USD 713.23M 105.18M